Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,584,875
+$10,782,529 QoQ
Shares Held
170,386
+109.7% QoQ
Ownership
0.190%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 334 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $802,494,373 across 36 Drug Manufacturers - Specialty & Generic names. LQDA ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
18,815,747 | $298,794,060 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
502,267 | $84,652,078 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
619,298 | $68,704,917 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
123,215 | $66,761,581 | |
| 5 | ZTS |
Zoetis Inc.
|
812,181 | $58,363,324 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
1,396,427 | $34,366,066 | |
| 7 | ALKS |
Alkermes plc.
|
630,325 | $33,029,029 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,581,869 | $27,382,151 |
All Filings in LQDA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,584,875 | 170,386 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $2,802,346 | 81,251 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $245,819 | 10,810 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $149,874 | 10,161 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||